Portfolio · AI Startups · Singapore

Veyra Health

AI triage and patient-routing infrastructure for clinic networks.

Growth advisoryAPAC expansionInvestor access

6

markets across SEA in 18 months

92%

triage accuracy in production

40+

clinic networks live

Overview

Veyra builds AI triage infrastructure that routes patients to the right care level before they reach a clinician, sold to clinic networks and telehealth providers across Southeast Asia.

Challenge

Healthcare buyers do not tolerate AI experiments. Every market in SEA has its own regulator, its own payer structure, and its own definition of clinical risk. Veyra's US-style land-fast playbook stalled immediately.

Strategy

We rebuilt expansion around regulatory sequencing: enter markets in the order their approval frameworks allow, anchor each entry with one flagship clinical partner, and let published outcomes carry the sales motion.

Execution

Advisory ran for six quarters covering market prioritisation, clinical-evidence packaging, and partner negotiations. The network provided introductions to two regional healthcare groups that became anchor customers.

Results

  • Live in six SEA markets within eighteen months
  • Anchor partnerships with two regional clinic groups
  • Clinical outcomes paper that now opens enterprise conversations

Lessons

In regulated categories, the expansion roadmap is the regulatory roadmap. Accepting that early turned compliance from a brake into the strategy itself.